GlassScriptPhysician profile
Shaun C Corbin
NPI 1669421814
$3,120.06
in general payments reported to CMS, 2019-2025
32 companies · $657 in 2025
The $657 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $69.89 · 2021: $529 · 2022: $448 · 2023: $448 · 2024: $537 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,608 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.59 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $508.94 | 2019-2025 | Inspire |
| Glaxosmithkline, LLC. | $417.45 | 2019-2025 | Nucala |
| Aerin Medical INC. | $347.34 | 2019-2025 | |
| Stryker Corporation | $267.30 | 2019-2025 | Scopis Ent, Shaver System |
| Regeneron Healthcare Solutions, INC. | $247.43 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $224.73 | 2019-2025 | |
| Genzyme Corporation | $152.17 | 2019-2025 | |
| Alk-Abello, INC | $77.84 | 2019-2022 | |
| Intersect Ent, INC. | $70.55 | 2019-2021 | |
| Acclarent, INC | $68.91 | 2023-2024 | Trudi Nav Cable |
| Boston Scientific Corporation | $68.23 | 2022-2025 | Wavewriter Alpha Prime 16 |
| 3b Medical, INC. | $65.56 | 2024-2025 | Luna |
| Astrazeneca Pharmaceuticals LP | $61.00 | 2023-2025 | Tezspire, Airsupra |
| Phathom Pharmaceuticals, INC. | $48.19 | 2025 | Voquezna |
| Smith+Nephew, INC. | $47.00 | 2024-2025 | Tula |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $43.59 | 2021-2022 | |
| Phadia US INC. | $38.16 | 2023-2024 | Immunocap |
| Medtronic, INC. | $35.59 | 2021-2024 | Arcpoint |
| Amgen INC. | $34.00 | 2025 | |
| Philips North America LLC | $30.18 | 2019 | |
| Acera Surgical, INC. | $26.38 | 2019 | |
| Pfizer INC. | $26.15 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.39 | 2025 | Elaprase |
| Biohaven Pharmaceutical Holding Company LTD. | $25.18 | 2022 | |
| Merck Sharp & Dohme LLC | $24.62 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $23.67 | 2025 | Neffy |
| Abbvie INC. | $23.36 | 2024 | |
| Hologic Sales and Service, LLC | $22.03 | 2023 | Coolseal Generator |
| Advanced Bionics, LLC | $19.58 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.45 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.56 | 2022 | |
| Lundbeck LLC | $15.53 | 2023 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Corbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.